Lithium and Valproic Acid in Bipolar Disorders and Beyond

Curr Neuropharmacol. 2023;21(4):890. doi: 10.2174/1570159X2104230307123319.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antimanic Agents / therapeutic use
  • Bipolar Disorder* / drug therapy
  • Humans
  • Lithium / therapeutic use
  • Lithium Compounds / therapeutic use
  • Valproic Acid* / therapeutic use

Substances

  • Valproic Acid
  • Lithium
  • Antimanic Agents
  • Lithium Compounds